La chaîne d'options affiche les données clés des options sur actions de Nurix Therapeutics à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Nurix Therapeutics..

Nurix Therapeutics (NASDAQ:NRIX) Stock, Chaîne d'Options

NURIX THERAPEUTICS INC

Nurix Therapeutics

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

Nurix Therapeutics Inc

Shares of ProShares UltraPro QQQ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TQQQ#NASDAQ">TQQQ</a>) surged 3.24% to $74.48 Friday afternoon as investors cheered stronger-than-expected <a href="https://www.benzinga.com/markets/economic-data/25/06/45820223/stocks-rally-on-strong-jobs-numbers-tesla-rebounds-as-trump-musk-feud-softens-whats-driving-markets-friday">U.S. labor data</a> and a broad rally in tech stocks.
What To Know: TQQQ is a leveraged ETF designed to deliver three times the daily performance of the Nasdaq-100 Index, making it especially sensitive to movements in high-growth tech names.
May&#8217;s nonfarm payrolls <a href="https://www.benzinga.com/markets/economic-data/25/06/45812372/us-labor-markets-defies-tariff-concerns-as-nonfarm-payrolls-wages-top-expectations-in-may">increased</a> by 139,000, topping economist forecasts of 130,000, while average hourly earnings rose 0.4%, the fastest monthly gain since January. The unemployment rate held steady at 4.2%. The robust data eased concerns about an economic slowdown and boosted confidence in consumer spending.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45819381/plug-power-stock-surges-13-whats-going-on">Plug Power Stock Surges 13%: What&#8217;s Going On?</a>
The Nasdaq-100 jumped 1% on the session, lifting TQQQ alongside it. Tech stocks led gains, with Tesla rebounding more than 5% following Thursday's steep drop. Market sentiment also improved after the White House downplayed tensions between Elon Musk and President Donald Trump.
Rising Treasury yields and a stronger dollar reflected expectations for continued economic strength, but it was the renewed momentum in large-cap tech that drove TQQQ's sharp advance. With the Nasdaq-100 nearing record highs, leveraged ETFs like TQQQ are benefiting from bullish bets on tech outperformance.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45820264/top-2-alternatives-to-tesla-after-the-musk-trump-breakup">Top 2 Alternatives To Tesla After The Musk-Trump Breakup</a>
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, TQQQ has a 52-week high of $93.78 and a 52-week low of $35.00.

News

TQQQ

ProShares UltraPro QQQ (TQQQ) Trades Higher On Strong Jobs Data, Tech Rally

WIIM

CLYM

Climb Bio shares are trading higher after Oppenheimer initiated its coverage on the stock with a Outperform rating and announced a price target of $10.

Wall Street analysts responded to Ciena Corp.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) second-quarter financial results on Thursday.
Ciena reported a <a target="_blank" href="https://www.benzinga.com/markets/large-cap/25/06/45790736/ciena-stock-slides-after-q2-eps-miss-margin-drop-despite-strong-sales" rel="noreferrer noopener">quarterly revenue growth</a> of 23.6% to $1.13 billion, beating the&nbsp;analyst consensus&nbsp;estimate of $1.09 billion.
The American telecommunications networking equipment and software services supplier reported an adjusted EPS of 42 cents,&nbsp;which missed the&nbsp;analyst consensus estimate&nbsp;of 52 cents.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/large-cap/25/06/45779192/ciena-ai-ambitions-face-margin-math-marvell-ous-analyst" rel="noreferrer noopener">Ciena Set To Beat Q2 Estimates But AI Ambitions Face Margin Math And Marvell-ous Rivals</a>
The adjusted gross margin declined by 250 bps to 41%, and the adjusted operating margin increased by 140 bps to 8.2%.
Rosenblatt analyst Mike Genovese maintained Ciena <a href="https://www.benzinga.com/quote/CIEN/analyst-ratings" target="_blank" rel="noreferrer noopener">with a Neutral</a> and lowered the price target from&nbsp;$85&nbsp;to&nbsp;$78.
Needham analyst Ryan Koontz reiterated Ciena with a Buy and a $90&nbsp;price target.
Rosenblatt: Genovese noted his Ciena preview was accurate since he expected increased revenue guidance. However, he was worried about margins because of customer and product mix and the time it could take to achieve the mid-40s gross margin and mid-teens operating margin targets.
The analyst said the gross margin was light because of a heavy sales mix of new line systems, which tend to get filled with high-margin cards later and 400ZR pluggable. The good news is that higher revenues appear sustainable.
Genovese said Cloud and Service Provider DCI markets can drive multi-year growth above 8% to 11%. The analyst noted Ciena will likely increase its multi-year revenue growth above this range before the end of fiscal 2025. He said the company has also won its first two Datacom Campus deals, including one likely to be worth hundreds of millions of dollars, with revenues slated to begin in 2026.
As per Genovese, the read for Datacom companies, like Lumentum Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITE#NASDAQ">LITE</a>) and Coherent Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>), is positive since Cloud capex is substantial and the 1.6+T Datacom products Ciena is moving over the next few years are expected to be good for the gross margins. 
The read is also positive for Telecom- and DCI-exposed names, like Viavi Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIAV#NASDAQ">VIAV</a>), Ribbon Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RBBN#NASDAQ">RBBN</a>) and ADTRAN Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTN#NASDAQ">ADTN</a>), since Telecom demand is strong and Ciena&#8217;s gross margins issues are company-specific, the analyst said.
For Ciena, he sought signs that margins are sustainably improving before potentially becoming more constructive in his rating.
Genovese projected fiscal 2025 revenue of $4.58 billion (prior $4.41 billion) and adjusted EPS of $2.24 (prior $2.43).
Needham: Ciena reported mixed fiscal second-quarter results, with revenue and adjusted EPS +3% and -10 cents versus consensus, and fiscal second-half guidance reflects meaningfully higher revenue growth but lower gross margin and EPS than expected.
Fiscal second-quarter strength in Cloud (+88% Y/Y) drove the outperformance and strong bookings (B2B &gt; 1), but new products that carry lower gross margins are increasing in mix faster than expected, the analyst said. 
Increased tariff costs also impact gross profit by ~$10 million per quarter, which he feared could worsen given uncertainties.
Koontz noted the stock pullback as a buying opportunity for a company with the industry&#8217;s best technology and customer relationships. The analyst expects Ciena to benefit from continued share gains and is enthused about emerging intra-data center opportunities in fiscal 2027, although less bullish on Switching and Broadband.
Koontz projected fiscal 2025 revenue of $4.57 billion (prior $4.44 billion) and adjusted EPS of $2.25 (prior $2.58).
CIEN Price Action: CIEN stock is up 0.22% at $73.29 at publication on Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="http://benzinga.com/markets/25/06/45785351/which-internet-software-stocks-is-jp-morgan-bullish-on" target="_blank" rel="noreferrer noopener">Which Internet Software Stocks Is JP Morgan Bullish On?</a> Photo: Michael Vi via Shutterstock</li>
</ul>

Price Target

Reiteration

Analyst Ratings

Tech

Trading Ideas

ADTN

CIEN

COHR

LITE

RBBN

VIAV

Ciena Poised For Growth On Cloud Demand, But Analysts Warn About Margin Pressure, Tariff Costs

AMTX

Aemetis shares are trading higher after Ascendiant Capital maintained its Buy rating on the stock and raised the price target from $19 to $20.

Shares of Recursion Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>) are trading higher after the company, in collaboration with MIT, announced the release of Boltz-2, a new open-source AI model designed to predict molecular binding affinity with <a href="https://www.benzinga.com/pressreleases/25/06/g45814396/mit-and-recursion-release-boltz-2-next-generation-ai-model-to-predict-binding-affinity-at-unpreced">unmatched speed and accuracy. </a>
What To Know: The model, which outperforms previous tools including AlphaFold3 and Recursion's own Boltz-1, is built to advance drug discovery by significantly accelerating early-stage molecular screening.
Boltz-2 is the first biomolecular foundation model to jointly predict molecular structure and binding affinity in a single framework. It approaches the precision of traditional physics-based free energy perturbation calculations while operating up to 1,000 times faster. This drastic increase in efficiency makes large-scale virtual screening more practical, reducing costs and removing a key bottleneck in identifying viable drug candidates.
The model was trained on Recursion's NVIDIA-powered BioHive-2 supercomputer and incorporates roughly five million binding affinity measurements. It also introduces more realistic simulations and greater control features for researchers. Recursion emphasized that the tool is fully open-source under an MIT license, allowing academic and commercial teams alike to use and adapt it freely.
The strong market reaction reflects investor optimism that Boltz-2 will give Recursion a competitive edge in the pharmaceutical AI space, where speed and predictive power are crucial for drug development success. The collaboration with MIT also reinforces Recursion's position at the intersection of advanced computing and biomedical research.
RXRX Price Action: Recursion Pharmaceuticals shares were up 18.4% at $5.41 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
Read Next:
<ul class="wp-block-list">
<li>Stocks Rally On Strong Jobs Numbers; Tesla Rebounds As Trump-Musk Feud Softens: What&#8217;s Driving Markets Friday?</li>
</ul>
Image Via Shutterstock.

Movers

RXRX

Recursion Pharmaceuticals Stock Surges On Breakthrough AI Model Launch With MIT

As global growth forecasts dim and trade tensions rattle markets, <a href="https://www.benzinga.com/money/best-dividend-stocks-to-buy-and-hold">high-dividend stocks</a> are stealing the spotlight. The OECD just <a href="https://www.benzinga.com/markets/equities/25/06/45752680/global-growth-forecast-cut-taco-and-blind-money-support-the-stock-market">slashed its U.S. GDP outlook</a> to 1.6% for 2025 from 2.2%, citing persistent policy uncertainty and trade friction. 
That's prompted investors to sharply pivot toward dividend payers—names that offer predictable income when price action gets erratic.
In an environment where the S&amp;P 500 <a href="https://www.multpl.com/s-p-500-dividend-yield/table/by-year">yields</a> a tepid 1.28%, cash-generating stalwarts with robust balance sheets and fat dividends are in high demand. Historically, dividend-paying stocks have outpaced non-payers by more than 2x in average annual returns, and June 2025 is shaping up to be no exception.
Read Also: <a href="https://www.benzinga.com/Opinion/25/06/45754902/under-the-radar-why-low-profile-dividend-stocks-could-be-your-best-asset">Under the Radar: Why Low-Profile Dividend Stocks Could Be Your Best Asset</a>
Here are three high-yield stocks &#8211; and one ETF &#8211; that are standing out in this market:
<h2 class="wp-block-heading">Realty Income Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/O#NYSE">O</a>) – Yield: 5.77%</h2>
The monthly payout machine continues to deliver, with 659 straight dividend checks and a rock-solid 75% AFFO payout ratio. 
Realty Income's <a href="https://www.realtyincome.com/sites/realty-income/files/2025-05/Quarterly_Investor_Presentation-Q1_2025.pdf">$23 billion</a> in first-quarter acquisition opportunities and A-rated credit make it a defensive pick as tariff negotiations linger.
<h2 class="wp-block-heading">Enterprise Products Partners LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPD#NYSE">EPD</a>) – Yield: 6.89%</h2>
Energy's volatility hasn't fazed this pipeline operator. Its fee-based model and <a href="https://ir.enterpriseproducts.com/news-releases/news-release-details/enterprise-reports-first-quarter-2025-earnings">$6 billion</a> in 2025 projects support a generous yield, without the commodity price drama. A steady cash-flow engine for income seekers.
<h2 class="wp-block-heading">OneMain Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMF#NYSE">OMF</a>) – Yield: 8.02%</h2>
With a 9.69% gain over the past month alone, OneMain Holdings blends high yield with capital appreciation. Its strong balance sheet gives investors confidence amid uncertain economic signals.
<h2 class="wp-block-heading">Schwab U.S. Dividend Equity ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHD#NYSE">SCHD</a>) – Yield: 3.96%</h2>
Prefer a hands-off approach? 
SCHD offers a diversified path to income with a 4% yield and holdings boasting 8.4% dividend growth over the past five years. It's a popular pick for those avoiding stock-specific risk.
As markets climb but face lingering macro uncertainty, income-focused strategies are staging a strong comeback. For investors looking to shield their portfolios while still collecting steady cash, these dividend leaders offer exactly that &#8211; without needing to call the market&#8217;s next move.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/06/45811222/wall-streets-most-accurate-analysts-give-their-take-on-3-financial-stocks-with-over-15-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Financial Stocks With Over 15% Dividend Yields</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Dividends

SCHD

High-Yield Stocks Flex Muscle As Growth Outlook Fades: 4 Dividend Plays To Watch In June

Know Labs Shares Resume Trade Following Circuit Breaker Halt

Rocket Lab Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) shares are trading higher Friday after the company announced the launch window for <a href="https://www.benzinga.com//node/45758874">its next mission</a>, &#8216;The Mountain God Guards,&#8217; for the Institute for Q-shu Pioneers of Space, Inc.
What To Know: Rocket Lab announced that the mission will launch from New Zealand during a launch window that opens on June 10, 2025 UTC.
The satellite is named QPS-SAR-11 (also known as YAMATSUMI-I) will join the iQPS network, where it will help capture detailed images of Earth and support global monitoring efforts.
The mission is part of Rocket Lab's ramped-up launch schedule for Electron, the world's most frequently launched small orbital rocket. It marks the company's third Electron launch in 24 days, the 66th Electron launch overall and the fourth dedicated mission for the iQPS satellite network.
"The Mountain God Guards" will also be Rocket Lab's eighth mission of 2025.
Related Link: <a href="https://www.benzinga.com/markets/large-cap/25/06/45814068/novo-nordisks-wegovy-tied-to-increased-risk-of-rare-vision-loss-disorder-european-regulators-say">Novo Nordisk&#8217;s Wegovy Tied To Increased Risk Of Rare Vision-Loss Disorder, European Regulators Say</a>
RKLB Price Action: At the time of writing, Rocket Lab shares are trading 8.11% higher at $28.62, according to data from Benzinga Pro.
Image: via Shutterstock

RKLB

Rocket Lab Stock Is Moving Higher Friday: What's Going On?

ADXN

Addex Therapeutics shares are trading higher after the company reported its preclinical results for GABAB PAM.

The cryptocurrency market is showing mixed signals to close the week. Bitcoin has edged back into the green, while major altcoins continue to struggle.
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>&nbsp;$104,572.38</td>
<td>+1.4%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>&nbsp;$2,495.00</td>
<td>-3.3%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>&nbsp;$148.95</td>
<td>-0.4%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>&nbsp;$2.16</td>
<td>+0.3%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>&nbsp;$0.1792</td>
<td>-0.05%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>&nbsp;$0.00001245</td>
<td>-1.1%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul class="wp-block-list">
<li>IntoTheBlock data shows large transaction volume decreasing by 3.6% and daily active addresses growing by 5.6%. Transactions greater than $100,000 are up from 11,237 to 11,851 in a single day. Exchanges netflows are down by 45.6%.</li>
<li>Coinglass data reports 199,310 traders were liquidated in the past 24 hours for $850.45 million.</li>
</ul>
Notable Developments:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45817913/blockchains-aws-moment-is-coming-says-wisdomtrees-jason-guthrie">Blockchain&#8217;s AWS Moment Is Coming, Says WisdomTree&#8217;s Jason Guthrie</a></li>
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45811290/doj-seeks-to-seize-7-7-million-in-bitcoin-ethereum-nfts-allegedly-laundered-by-north-korean-it-workers">DOJ Seeks To Seize $7.7 Million In Bitcoin, Ethereum, NFTs Allegedly Laundered By North Korean IT Workers</a></li>
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45813023/trump-musk-infight-sparks-50-million-kill-big-beautiful-bill-meme-coin-but-on-chain-experts-warn-to-steer-clear-of-it">Trump-Musk Infight Sparks $50 Million &#8216;Kill Big Beautiful Bill&#8217; Meme Coin, But On-Chain Experts Warn To Steer Clear Of It</a></li>
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45801402/bitcoins-moonshot-can-microstrategy-and-coinbase-keep-riding-the-crypto-wave">Bitcoin&#8217;s Moonshot: Can MicroStrategy And Coinbase Keep Riding The Crypto Wave?</a></li>
</ul>
Top Losers:
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Stacks (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/stx/usd">STX</a>)</td>
<td>$0.6320</td>
<td>-12.9%</td>
</tr>
<tr>
<td>Lido DAO (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">LDO</a>)</td>
<td>$0.7660</td>
<td>-8.6%</td>
</tr>
<tr>
<td>Celestia (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TIA</a>)</td>
<td>$1.95</td>
<td>-7.1%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Renowned analyst Byzantine General <a href="https://x.com/ByzGeneral/status/1931031497852522703">believes</a> Bitcoin may be setting up a major bear trap, currently testing diagonal resistance. 
He highlights that Friday's price action will be pivotal, a breakout could confirm the trap, while a rejection might reinforce bearish sentiment.
Crypto Caesar observed that Bitcoin has bounced cleanly from a previously marked support level, a positive sign, but warns that volatility is far from over as uncertainty lingers.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> &#8211; <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> bounced exactly from our support level for now. Be prepared for more volatile days. I don&#39;t know if the storm is really over now. <a href="https://t.co/758dBdk5JA">pic.twitter.com/758dBdk5JA</a>
&mdash; Crypto Caesar (@CryptoCaesarTA) <a href="https://twitter.com/CryptoCaesarTA/status/1930926714911158517?ref_src=twsrc%5Etfw">June 6, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Meanwhile, Rekt Capital <a href="https://x.com/rektcapital/status/1931046546717786262">sees</a> the current retest holding, which he considers a short-term bullish signal, though he urges traders to wait for confirmation before acting decisively.
Daan Crypto Trades <a href="https://x.com/DaanCrypto/status/1930996686073090475">projects</a> a ranging market in the coming weeks, following Bitcoin's strong start to the month. With BTC hovering near the mid-range and monthly open at $104,600, he outlines two key scenarios:
<ul class="wp-block-list">
<li>Breakout above range highs → signals continuation of the uptrend, with new all-time highs on the table.</li>
<li>Drop below ~$100,000 (Thursday's low) → confirms breakdown and likely extends weakness for another 1–2 weeks.</li>
</ul>
His base case is more sideways action, and he emphasizes caution to avoid getting caught in fakeouts.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45801101/3-ways-how-the-strategic-bitcoin-reserve-could-be-funded">3 Ways How The Strategic Bitcoin Reserve Could Be Funded</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

$ETH

$LDO

$SHIB

$SOL

$STX

$TIA

$XRP

GBTC

Bitcoin Crawls Into Green Zone, But Ethereum, XRP, Dogecoin Struggle

DFDV

DeFi Development shares are trading higher after the company announced a partnership with Drift Protocol to list the dfdvSOL liquid staking token.

VERO

Venus Concept shares are trading higher after the company announced a $1.15 million registered direct offering of common stock at $2.65 per share, along with a concurrent private placement of unregistered warrants, potentially raising up to $2.3 million.

Shares of HIVE Digital Technologies Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIVE#NASDAQ">HIVE</a>) surged 9.89% to $2.00 Friday afternoon after the company announced an operational achievement in its Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) mining capacity.
What To Know: The Vancouver-based firm <a href="https://www.benzinga.com/pressreleases/25/06/45807768/hive-digital-technologies-achieves-58-peak-hashrate-growth-in-one-month-surpasses-10-ehs-in-may-202">reported</a> a 58% increase in peak hash rate in May, reaching 10.4 exahash per second (EH/s), up from 6.6 EH/s in April. HIVE now exceeds 1% of the global Bitcoin network hashrate.
The growth was largely driven by the activation of a 100 MW hydro-powered facility in Paraguay, bolstering HIVE&#8217;s position in sustainable digital infrastructure. With operations spanning nine time zones and five languages, HIVE uses 100% renewable hydroelectric power across its data centers.
Read Also: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45817330/shiba-inu-slides-4-5-on-the-week-why-is-it-going-down">Shiba Inu Slides 4.5% On The Week: Why Is It Going Down?</a>
In May, HIVE <a href="https://www.benzinga.com/pressreleases/25/06/45807768/hive-digital-technologies-achieves-58-peak-hashrate-growth-in-one-month-surpasses-10-ehs-in-may-202">mined</a> 139 Bitcoin, averaging 4.5 BTC per day, and aims to surpass 5 BTC daily in June. The company expects to hit 11.5 EH/s by month-end and 25 EH/s by Q4 2025. Executives noted the company's ability to deploy new ASIC miners within six hours, rapidly converting hardware into revenue.
CEO Aydin Kilic emphasized efficiency improvements, projecting production costs below $50,000 per Bitcoin as the company targets 18 EH/s this summer and over 12 BTC daily output by year-end.
Read Also: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45801402/bitcoins-moonshot-can-microstrategy-and-coinbase-keep-riding-the-crypto-wave">Bitcoin&#8217;s Moonshot: Can MicroStrategy And Coinbase Keep Riding The Crypto Wave?</a>
<h2 class="wp-block-heading">How To Buy HIVE Stock</h2>
By now you're likely curious about how to participate in the market for HIVE Digital Technologies &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of HIVE Digital Technologies, which is trading at $2.0 as of publishing time, $100 would buy you 50.0 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, HIVE has a 52-week high of $5.54 and a 52-week low of $1.26.
Image: Shutterstock

HIVE

HIVE Digital Technologies Stock Jumps 10% On Bitcoin Mining Milestone

Financial giants have made a conspicuous bullish move on Caterpillar. Our analysis of options history for Caterpillar (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>) revealed 19 unusual trades.
Delving into the details, we found 47% of traders were bullish, while 42% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $108,280, and 16 were calls, valued at $1,389,408.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $300.0 to $390.0 for Caterpillar over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Caterpillar's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Caterpillar's substantial trades, within a strike price spectrum from $300.0 to $390.0 over the preceding 30 days.
<h3>Caterpillar Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749236644_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CAT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$71.35</td>
<td>$70.6</td>
<td>$71.11</td>
<td>$300.00</td>
<td>$483.4K</td>
<td align="right">273</td>
<td align="right">72</td>
</tr>
<tr>
<td>CAT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$42.45</td>
<td>$42.15</td>
<td>$42.15</td>
<td>$360.00</td>
<td>$168.6K</td>
<td align="right">239</td>
<td align="right">152</td>
</tr>
<tr>
<td>CAT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$42.45</td>
<td>$41.1</td>
<td>$42.15</td>
<td>$360.00</td>
<td>$168.6K</td>
<td align="right">239</td>
<td align="right">112</td>
</tr>
<tr>
<td>CAT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$41.25</td>
<td>$40.55</td>
<td>$41.25</td>
<td>$320.00</td>
<td>$82.5K</td>
<td align="right">215</td>
<td align="right">20</td>
</tr>
<tr>
<td>CAT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/27/25</td>
<td>$4.7</td>
<td>$4.25</td>
<td>$4.3</td>
<td>$365.00</td>
<td>$81.7K</td>
<td align="right">25</td>
<td align="right">200</td>
</tr>
</tbody>
</table>

<h3>About Caterpillar</h3>
Caterpillar is the world's leading manufacturer of construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines and diesel-electric locomotives. Its reporting segments are: construction industries (40% sales/47% operating profit, or OP), resource industries (20% sales/19% OP), and energy &amp; transportation (40% sales/34% OP). Market share approaches 20% across many products. Caterpillar operates a captive finance subsidiary to facilitate sales. The firm has global reach (46% US sales/54% ex-US). Construction skews more domestic, while the other divisions are more geographically diversified. An independent network of 156 dealers operates approximately 2,800 facilities, giving Caterpillar reach into about 190 countries for sales and support services.
Having examined the options trading patterns of Caterpillar, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Caterpillar Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 944,863, with CAT's price up by 1.28%, positioned at $353.42.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 60 days.</li>
</ul>
<h3>What Analysts Are Saying About Caterpillar</h3>
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $375.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from UBS has elevated its stance to Neutral, setting a new price target at $357. 
&#x2A; Maintaining their stance, an analyst from Evercore ISI Group continues to hold a In-Line rating for Caterpillar, targeting a price of $373. 
&#x2A; An analyst from Baird upgraded its action to Outperform with a price target of $395. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Caterpillar with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

Markets

Check Out What Whales Are Doing With CAT

Investors with a lot of money to spend have taken a bullish stance on Constellation Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with CEG, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 12 options trades for Constellation Energy.
This isn't normal.
The overall sentiment of these big-money traders is split between 58% bullish and 8%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $250,524, and 11, calls, for a total amount of $668,761.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $200.0 and $350.0 for Constellation Energy, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Constellation Energy's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Constellation Energy's substantial trades, within a strike price spectrum from $200.0 to $350.0 over the preceding 30 days.
<h3>Constellation Energy Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749236638_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CEG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/06/25</td>
<td>$21.0</td>
<td>$16.9</td>
<td>$18.49</td>
<td>$312.50</td>
<td>$250.5K</td>
<td>212</td>
<td align="right">131</td>
</tr>
<tr>
<td>CEG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$103.5</td>
<td>$102.8</td>
<td>$103.5</td>
<td>$200.00</td>
<td>$103.5K</td>
<td>1.5K</td>
<td align="right">10</td>
</tr>
<tr>
<td>CEG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>07/18/25</td>
<td>$5.4</td>
<td>$5.2</td>
<td>$5.37</td>
<td>$330.00</td>
<td>$94.3K</td>
<td>463</td>
<td align="right">197</td>
</tr>
<tr>
<td>CEG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$90.0</td>
<td>$88.8</td>
<td>$90.0</td>
<td>$220.00</td>
<td>$90.0K</td>
<td>396</td>
<td align="right">10</td>
</tr>
<tr>
<td>CEG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$25.1</td>
<td>$25.1</td>
<td>$25.1</td>
<td>$350.00</td>
<td>$75.3K</td>
<td>559</td>
<td align="right">13</td>
</tr>
</tbody>
</table>

<h3>About Constellation Energy</h3>
Constellation Energy Corp producer of carbon-free energy and a supplier of energy products and services. The company offers generating capacity that includes nuclear, wind, solar, natural gas, and hydroelectric assets. It sells electricity, natural gas, and other energy-related products and sustainable solutions to various types of customers, including distribution utilities, municipalities, cooperatives, and commercial, industrial, public sector, and residential customers in markets across multiple geographic regions. Its operating segments and reporting units are Mid-Atlantic, Midwest, New York, ERCOT, and Other Power Regions.
In light of the recent options history for Constellation Energy, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of Constellation Energy</h3>
<ul>
<li>With a volume of 2,500,213, the price of CEG is up 2.18% at $296.2. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 60 days.</li>
</ul>
<h3>Expert Opinions on Constellation Energy</h3>
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $335.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from BMO Capital keeps a Outperform rating on Constellation Energy with a target price of $350. 
&#x2A; An analyst from BMO Capital has decided to maintain their Outperform rating on Constellation Energy, which currently sits at a price target of $337. 
&#x2A; In a cautious move, an analyst from Citigroup downgraded its rating to Neutral, setting a price target of $318. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Constellation Energy options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Constellation Energy's Options Frenzy: What You Need to Know

Investors with a lot of money to spend have taken a bearish stance on Target (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with TGT, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 24 uncommon options trades for Target.
This isn't normal.
The overall sentiment of these big-money traders is split between 37% bullish and 58%, bearish.
Out of all of the special options we uncovered, 9 are puts, for a total amount of $771,412, and 15 are calls, for a total amount of $1,000,669.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $80.0 to $125.0 for Target over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Target stands at 2285.0, with a total volume reaching 3,380.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Target, situated within the strike price corridor from $80.0 to $125.0, throughout the last 30 days.
<h3>Target Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749236632_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TGT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$16.7</td>
<td>$15.0</td>
<td>$15.5</td>
<td>$100.00</td>
<td>$310.0K</td>
<td>1.7K</td>
<td align="right">200</td>
</tr>
<tr>
<td>TGT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$11.9</td>
<td>$11.4</td>
<td>$11.5</td>
<td>$85.00</td>
<td>$287.5K</td>
<td>2.8K</td>
<td align="right">250</td>
</tr>
<tr>
<td>TGT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/17/25</td>
<td>$7.6</td>
<td>$7.45</td>
<td>$7.5</td>
<td>$100.00</td>
<td>$150.0K</td>
<td>722</td>
<td align="right">596</td>
</tr>
<tr>
<td>TGT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$6.95</td>
<td>$6.65</td>
<td>$6.85</td>
<td>$100.00</td>
<td>$137.0K</td>
<td>1.3K</td>
<td align="right">200</td>
</tr>
<tr>
<td>TGT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$31.35</td>
<td>$30.55</td>
<td>$30.55</td>
<td>$125.00</td>
<td>$122.2K</td>
<td>3.3K</td>
<td align="right">40</td>
</tr>
</tbody>
</table>

<h3>About Target</h3>
Target serves as the nation's seventh-largest retailer, with its strategy predicated on delivering a gratifying in-store shopping experience and a wide product assortment of trendy apparel, home goods, and household essentials at competitive prices. Target's upscale and stylish image began to carry national merit in the 1990s—a decade in which the brand saw its top line grow threefold to almost $30 billion—and has since cemented itself as a leading US retailer.Today, Target operates over 1,900 stores in the United States, generates over $100 billion in sales, and fulfills over 2 billion customer orders annually. The firm's vast footprint is concentrated in urban and suburban markets as the firm seeks to appeal to a more affluent consumer base.
After a thorough review of the options trading surrounding Target, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Target's Current Market Status</h3>
<ul>
<li>With a trading volume of 5,030,414, the price of TGT is up by 3.48%, reaching $96.77.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 75 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Target</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $111.4.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Telsey Advisory Group continues to hold a Outperform rating for Target, targeting a price of $130. 
&#x2A; An analyst from DA Davidson has decided to maintain their Buy rating on Target, which currently sits at a price target of $125. 
&#x2A; An analyst from JP Morgan has decided to maintain their Neutral rating on Target, which currently sits at a price target of $109. 
&#x2A; An analyst from Goldman Sachs has decided to maintain their Neutral rating on Target, which currently sits at a price target of $90. 
&#x2A; An analyst from RBC Capital persists with their Outperform rating on Target, maintaining a target price of $103. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Target, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Unpacking the Latest Options Trading Trends in Target

Circle Internet Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>), the issuer of the USDC stablecoin, made a powerful public debut this week, with shares surging 37.8% to $114.57 Friday following Thursday's IPO. The stock opened at $69, more than double its $31 IPO price, giving the company an initial valuation of $6.9 billion.
What To Know: Circle <a href="https://www.benzinga.com/pressreleases/25/06/b45782777/circle-announces-pricing-of-upsized-initial-public-offering">raised</a> approximately $1.1 billion by offering 34 million Class A shares, including 14.8 million from the company and 19.2 million from selling shareholders. The company also granted underwriters a 30-day option to purchase an additional 5.1 million shares.
This IPO marks a <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45800399/circle-surges-to-69-in-nyse-debut-raising-1-1b-as-investors-bet-on-stablecoins-going-mainstream">milestone</a> for Circle after a failed SPAC attempt in 2021. The listing comes amid broader market caution, with many firms issuing conservative guidance as earnings season ends. However, Circle's USDC, a dollar-backed stablecoin, is seeing rising demand for use in digital payments, cross-border transactions and treasury operations.
Analysts cite growing regulatory clarity in the U.S. and a recent Deutsche Bank <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45800399/circle-surges-to-69-in-nyse-debut-raising-1-1b-as-investors-bet-on-stablecoins-going-mainstream">report</a> predicting stablecoins are nearing mainstream adoption. Circle's debut is being viewed not just as a tech IPO, but as a key step in the integration of stablecoins into global finance.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45816602/broadcom-stock-is-trading-lower-friday-whats-going-on">Broadcom Stock Is Trading Lower Friday: What&#8217;s Going On?</a>
<h2 class="wp-block-heading">How To Buy CRCL Stock</h2>
By now you're likely curious about how to participate in the market for Circle Internet Group &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
Image: Shutterstock

CRCL

Circle (CRCL) Stock Surges After Successful IPO Debut: What's Going On?

A feud between Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk and President Donald Trump escalated Thursday with comments made in interviews and <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45805173/musk-vs-trump-tesla-suffers-record-152b-one-day-crash-as-ceo-warns-tariffs-will-cause-a-recession">across social media.</a>
The fight sent shares of Tesla lower Thursday and the stock could go lower with the potential for Trump to harm the electric vehicle sector and the company.
What Happened: Musk's opposition to the "Big Beautiful Bill" saw Trump <a href="https://www.benzinga.com/news/politics/25/06/45800612/trump-says-musk-has-trump-derangement-syndrome-as-battle-over-bill-heats-up-had-a-great-relationship-dont-know-if-we-will-anymore">accuse the Tesla CEO</a> of only speaking out in opposition due to the bill hurting EV tax credits and his own company.
A series of back-and-forth messages on social media saw some attacks against Tesla and the government and some personal attacks.
"This is an unfortunate episode from Elon, who is unhappy with the One Big Beautiful Bill because it does not include the policies he wanted. The President is focused on passing the historic piece of legislation and making our country great again," White House Press Secretary Karoline Leavitt told Benzinga when asked for comment on some tweets made by Musk.
Tesla stock posted its biggest one-day market capitalization fall on Thursday, with investors worried about the damage the fight could cause to Musk-related companies.
Trump threatened to pull government subsidies related to SpaceX and already planned to remove EV tax credits, which could harm Tesla and the overall electric vehicle sector. Here's a look at some of the areas that could be impacted.
Robotaxi Concerns: Given Trump&#8217;s past opposition to autonomous vehicles, or robotaxis, one area that could be closely watched now is the future of these vehicles.
Hours before Musk unveiled the Tesla Cybercab in California on Oct. 10, 2024, Trump spoke at the Detroit Economic Club and <a href="https://www.benzinga.com/general/politics/24/10/41298125/maybe-musk-missed-the-memo-trumps-plan-to-ban-autonomous-vehicles-could-sour-friendship" target="_blank" rel="noreferrer noopener">took on autonomous vehicles.</a>
&#8220;Do you like autonomous? Does anybody like an autonomous vehicle? Know what that is? Right? When you see a car driving along? Some people do, I don&#8217;t know. A little concerning to me, but the autonomous vehicles we&#8217;re going to stop from operating on American roads," Trump said.
Trump&#8217;s comments came despite his growing friendship with Musk, who had been campaigning for him in the 2024 election.
After once threatening to ban autonomous vehicles in America, Trump appeared to have had a <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42046316/trump-set-to-hand-musk-golden-path-for-tesla-after-reversing-course-on-autonomous-vehicle-ban">change of heart </a>and eased restrictions on self-driving vehicles. The reversal could help Tesla in its push to expand FSD and bring robotaxis to the market.
With Tesla set to launch its robotaxi service in Texas next week, all eyes will be on Trump to see if he reverses course again on the issue.
Read Also: <a href="https://www.benzinga.com/general/space/25/05/45680115/tesla-the-best-elon-musk-company-84-say-no-these-3-rank-higher">Tesla The Best Elon Musk Company? 84% Say No — These 3 Rank Higher</a>
Tesla Brand Damage: Tesla has suffered from brand damage in the last year. A series of protests took on the EV company, and some owners traded in their vehicles due to Musk's political push.
Previously appealing to fans of clean energy initiatives and Silicon Valley investors, Tesla appeared to change its target demographic with Trump supporters and MAGA (Make America Great Again) fans buying Tesla vehicles to show support for Musk and his backing of the president.
With a feud between Trump and Musk now escalated, Trump fans might be the last people who want to buy a Tesla vehicle.
A <a href="https://nypost.com/2025/06/06/us-news/trump-wants-to-sell-tesla-he-bought-to-support-for-elon-musk-white-house/?utm_source=twitter&amp;utm_campaign=nypost_business&amp;utm_medium=social">report </a>on Friday from the New York Post said Trump is planning to sell or give away the red Tesla Model S he bought on the<a href="https://www.benzinga.com/general/education/25/03/44289061/why-trumps-new-tesla-wont-be-hitting-the-open-road"> White House lawn </a>in a show of public support for Musk and Tesla at the time, as the brand saw several violent attacks against stores and vehicles.
While Trump can not drive the vehicle due to presidential rules, he said he would leave it on the White House lot for staff use.
Trump selling his Tesla vehicle could be negative for the EV company and show that his support for it has been withdrawn.
Other Areas: In addition to the above-mentioned items, Trump's plan to end the $7,500 EV tax credit will hurt Tesla and the sector.
Musk has been supportive of ending this incentive and analysts say it could actually help the company and crush Tesla's rivals in the sector.
The Tesla CEO and his companies have been under past and current investigations by many government organizations including the SEC and DOJ. While working with the government through the Department of Government Efficiency, Musk replaced the leaders at some of the organizations that investigate and regulate his companies.
The rift between Musk and Trump could lead to a return of investigations against the CEO and his companies.
Musk and his SpaceX company have received government contracts in the past and those could come under question, as Trump seemed to signal in one social media post. Trump said government subsidies and contracts that help Musk could be terminated to save billions of dollars. Musk indicated that he could end the SpaceX Dragon program, which has brought astronauts to and from the International Space Station.
SpaceX's Starlink was also in talks to secure deals with the FAA and is a major player in providing internet in humanitarian efforts and international conflict areas like Ukraine. The battle between Trump and Musk could put into question whether Trump could try to block Musk's efforts.
TSLA Price Action: Tesla stock is up 5.8% to $301.09 on Friday versus a 52-week trading range of $167.41 to $488.54. Tesla stock is down 20.7% year-to-date in 2025, with shares falling over 12% in the last five days.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/24/11/42023767/tesla-owners-who-dont-like-musk-are-letting-bumper-stickers-do-the-talking">Tesla Owners Who Don&#8217;t Like Musk Are Letting Bumper Stickers Do The Talking</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Politics

TSLA

Trump Vs. Musk: President Selling His Tesla — Is Targeting Robotaxis Next?

JPMorgan analyst Pinjalim Bora lowered the price forecast for Braze, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) from $45 to $47, <a href="https://www.benzinga.com/quote/BRZE/analyst-ratings" target="_blank" rel="noreferrer noopener">while retaining an Overweight rating</a>.
On Thursday, the company posted quarterly earnings of seven cents per share, which beat the analyst consensus estimate of five cents per share and sales of $162.06 million, which beat the analyst consensus <a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/45817048/braze-analysts-slash-their-forecasts-after-q1-earnings" target="_blank" rel="noreferrer noopener">estimate of $158.66 million</a>.
Braze lowered its FY2026 adjusted EPS guidance from 31 cents to 35 cents, but raised its FY2026 sales outlook from $686 million-$691 million <a href="https://www.benzinga.com/calendars/guidance" target="_blank" rel="noreferrer noopener">to $702 million-$706 million</a>.
The analyst notes that Braze began the year well, with all metrics exceeding guidance, though the company guidance added some noise as layered in a recent acquisition.
Bora writes that Braze noted global trade concerns haven&#8217;t materially impacted deal cycles, observing broad strength across industries and good momentum in the Americas and EMEA.
While full-year revenue guidance increased, full-year operating margins reset ~300bps lower post-acquisition, incorporating OfferFit&#8217;s full <a href="https://www.benzinga.com/pressreleases/25/06/b45733611/braze-completes-acquisition-of-offerfit">cost profile, adds the analyst</a>.
Though investors might be cautious about this temporary deviation from margin expansion, the analyst views OfferFit as a strategic long-term move.
Overall, Bora remains encouraged by these results and Braze&#8217;s long-term prospects as it continues to out-innovate peers by redefining the marketing tech stack and solidifying its role as a critical first-party data provider.
The analyst slashed adjusted EPS estimates to 17 cents (from 36 cents) for FY26 and 40 cents (from 61 cents) for FY27.
BRZE Price Action: Braze shares are down 18.06% at $29.58 at publication on Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/25/04/44672420/pros-global-e-sps-commerce-stand-out-as-tariffs-reshape-software-spending-priorities-analyst" target="_blank" rel="noreferrer noopener">PROS, Global-E, SPS Commerce Stand Out As Tariffs Reshape Software Spending Priorities: Analyst</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Equities

Mid Cap

BRZE

JPMorgan Trims Braze EPS Outlook As Investors React To Acquisition Growing Pains

In the latest quarter, 11 analysts provided ratings for Corteva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTVA#NYSE">CTVA</a>), showcasing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $74.91, a high estimate of $92.00, and a low estimate of $69.00. Witnessing a positive shift, the current average has risen by 5.06% from the previous average price target of $71.30.
<img src="https://www.benzinga.com/files/images/story/2025/1749236475_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The standing of Corteva among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Laurence Alexander</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$92.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Benjamin Theurer</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$70.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Richard Garchitorena</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$79.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Kristen Owen</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$75.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Vincent Andrews</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$71.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$78.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$72.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$76.00</td>
<td>$74.00</td>
</tr>
<tr>
<td>Bradley Thomas</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$71.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Bill Selesky</td>
<td>Argus Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$69.00</td>
<td>$69.00</td>
</tr>
<tr>
<td>Duffy Fischer</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Buy</td>
<td>$71.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Corteva. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Corteva compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Corteva's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CTVA/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Corteva analyst ratings.</a>
<h2>Get to Know Corteva Better</h2>
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.
<h3>Breaking Down Corteva's Financial Performance</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Negative Revenue Trend: Examining Corteva's financials over 3M reveals challenges. As of 31 March, 2025, the company experienced a decline of approximately -1.67% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.
Net Margin: Corteva's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 14.76%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Corteva's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.71% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Corteva's ROA excels beyond industry benchmarks, reaching 1.57%. This signifies efficient management of assets and strong financial health.
Debt Management: Corteva's debt-to-equity ratio is below the industry average at 0.17, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTVA

Expert Outlook: Corteva Through The Eyes Of 11 Analysts

Health Care

Press Releases

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nurix Announces FDA Clearance of IND Application for GS-6791/NX-0479 - a Novel IRAK4 Degrader for Inflammatory Conditions

Nurix Therapeutics Presents Positive Preclinical Data at the AACR 2025 Annual Meeting from Multiple Orally Available, Brain Penetrant Degraders Against Three High Value Oncology Targets

Nurix Therapeutics Presents Data at the AACR 2025 Annual Meeting Highlighting the Transformative Potential of Its Proprietary DEL-AI Platform Leveraging Machine Learning to Speed the Discovery of Novel Drugs

Nurix Therapeutics Announces Presentations of Clinical Data at the 30th European Hematology Association Congress and the 18th International Conference on Malignant Lymphoma

Nurix Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference

Nurix Therapeutics to Participate in the Jefferies Global Healthcare Conference

Sanofi Exercises License Extension Option to Nurix's STAT6 Program

Nurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congress (EHA2025)

Comments

Nurix Therapeutics

Nurix Therapeutics (NRIX) Options

Nurix Therapeutics (NASDAQ:NRIX) Stock, Chaîne d'Options

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL